NCT05965180Recruiting
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Source: ClinicalTrials.gov · Last updated 24 Nov 2025
Brief summary (registry, in English)
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 27 Apr 2023
- Start date
- Oct 2023
- Primary completion date
- Oct 2026
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT05965180
What you commit to
- Study type: Observational
- Planned participants: 50
- From Oct 2023 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 2\) Patients taking anticoagulants, no matter doses or washout time
Other illness
- 1\) Known history of bleeding disorders or
- 3\) Known allergy to silicone material
Other
- 4\) Unable to provide informed consent
- 5\) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded
- 6\) Involved in other investigational studies.
Who the study is looking for
- 1\) Planned prostate biopsy as part of routine clinical care
- 2\) \> 40 and \<80 years old
Age in the registry: 40 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Rogel Cancer Center Coordinator of this site? Confirm its status | Ann Arbor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.